Clinical Trial Update: Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating efficacy, immunogenicity, and safety of BBIBP-CorV vaccine against COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Disease

Drugs mentioned

• BBIBP-CorV

Snippet

Sponsor: International Vaccine Institute | Conditions: COVID-19 Disease | Phase 3 | Status: UNKNOWN